New diagnostic test offers early detection of osteoarthritis

Wiley Dec 18 2024

Diagnosing osteoarthritis often occurs in the late stages when cartilage degradation is severe, making it difficult to distinguish it from other types of arthritis and to determine the best treatment plan. In work published in the Journal of Orthopaedic Research, investigators have developed and tested a new diagnostic test that uses two markers found in the synovial fluid of patients' joints.

After assessing levels of cartilage oligomeric matrix protein and interleukin‐8, the team came up with an algorithm based on the ratio of these two markers and validated its efficacy in differentiating osteoarthritis from inflammatory arthritis in 171 human knee synovial fluid specimens. This study addresses an unmet need for objective diagnosis of osteoarthritis to improve clinical decision-making and patient outcomes."

Daniel Keter, BA, corresponding author of CD Diagnostics, A Division of Zimmer Biomet Source:

WileyJournal reference:

Keter, D., et al. (2024). Synovial fluid dual‐biomarker algorithm accurately differentiates osteoarthritis from inflammatory arthritis. Journal of Orthopaedic Research. doi.org/10.1002/jor.26005.

Articles You May Like

Ethereum Whales Control 43% Of Supply – What This Means For Retail Traders
Top Analyst Reports Massive Breakout For XRP Price, Eyes $10 As Next Milestone
Crypto Monthly Trading Volume Drops for First Time in Seven Months to $6.58T
Ethereum Futures Market Shows Renewed Optimism: Is a Break Above $3.5K Near?
XRP Price Gains 10%, Stealing The Spotlight from Bitcoin